Use of Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A 1 Year Real-Life Study

Little information is available from real-life studies evaluating the efficacy of guselkumab in moderate-to-severe psoriasis. In this real-life study, we retrospectively examined a database of 52 patients with moderate-to-severe psoriasis treated with guselkumab (100 mg, s.c.) and followed for 1 yea...

Descripción completa

Detalles Bibliográficos
Autores principales: Galluzzo, Marco, Tofani, Lorenzo, Lombardo, Paolo, Petruzzellis, Alessandra, Silvaggio, Dionisio, Egan, Colin Gerard, Bianchi, Luca, Talamonti, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408922/
https://www.ncbi.nlm.nih.gov/pubmed/32659978
http://dx.doi.org/10.3390/jcm9072170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408922/
https://www.ncbi.nlm.nih.gov/pubmed/32659978
http://dx.doi.org/10.3390/jcm9072170

Ejemplares similares